Back to Trades
GOLDSTEIN DOV A MD
DirectorCIK 0001120478
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 3
- Active
- 2025–2026
GOLDSTEIN DOV A MD, Director, has filed 7 SEC reports (2025–2026), spread across 3 companies, totaling $3.3M in disclosed volume. Weighing $0 bought versus $531.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 17 | GANX Gain Therapeutics, Inc. | GOLDSTEIN DOV A MD | Director | Award | $42.0K |
| Feb 19 | BIOA BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Insider | Award | $2.2M |
| Feb 3 | BIOA BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Insider | Exercise | $31.0K |
| Jan 21 | BIOA BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Insider | Exercise | $31.0K |
| Jan 15 | BIOA BioAge Labs, Inc. | GOLDSTEIN DOV A MD | Insider | Sell | $531.8K |
| Jan 6 | COYA Coya Therapeutics, Inc. | GOLDSTEIN DOV A MD | Insider | Award | $56.5K |
| Aug 19 | COYA Coya Therapeutics, Inc. | GOLDSTEIN DOV A MD | Director | Exercise | $38.3K |
7 filings